Carmelina A. Iannuzzi

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma.

Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma.

Journal: Cell death & disease

Published: June 11, 2026

NONO Protein Regulates the Immune Response in Human Triple-Negative Breast Cancer Cells.

NONO Protein Regulates the Immune Response in Human Triple-Negative Breast Cancer Cells.

Journal: International journal of molecular sciences

Published: August 03, 2025

Castalin Induces ROS Production, Leading to DNA Damage and Increasing the Activity of CHK1 Inhibitor in Cancer Cell Lines.

Castalin Induces ROS Production, Leading to DNA Damage and Increasing the Activity of CHK1 Inhibitor in Cancer Cell Lines.

Journal: Antioxidants (Basel, Switzerland)

Published: August 03, 2025

The modulation of AUF1 regulates the R-loop resolution activating the immune response in DDR.

The modulation of AUF1 regulates the R-loop resolution activating the immune response in DDR.

Journal: iScience

Published: July 01, 2025

Oleanolic Acid Modulates DNA Damage Response to Camptothecin Increasing Cancer Cell Death.

Oleanolic Acid Modulates DNA Damage Response to Camptothecin Increasing Cancer Cell Death.

Journal: International journal of molecular sciences

Published: October 07, 2024

Pharmacological inhibition of CDK4/6 impairs diffuse pleural mesothelioma 3D spheroid growth and reduces viability of cisplatin-resistant cells.

Pharmacological inhibition of CDK4/6 impairs diffuse pleural mesothelioma 3D spheroid growth and reduces viability of cisplatin-resistant cells.

Journal: Frontiers in oncology

Published: April 17, 2024

CDK9-55 guides the anaphase-promoting complex/cyclosome (APC/C) in choosing the DNA repair pathway choice.

CDK9-55 guides the anaphase-promoting complex/cyclosome (APC/C) in choosing the DNA repair pathway choice.

Journal: Oncogene

Published: October 27, 2023

The hydrophilic extract from a new tomato genotype (named DHO) kills cancer cell lines through the modulation of the DNA damage response induced by Campthotecin treatment.

The hydrophilic extract from a new tomato genotype (named DHO) kills cancer cell lines through the modulation of the DNA damage response induced by Campthotecin treatment.

Journal: Frontiers in oncology

Published: December 06, 2022

The Oncolytic Caprine Herpesvirus 1 (CpHV-1) Induces Apoptosis and Synergizes with Cisplatin in Mesothelioma Cell Lines: A New Potential Virotherapy Approach.

The Oncolytic Caprine Herpesvirus 1 (CpHV-1) Induces Apoptosis and Synergizes with Cisplatin in Mesothelioma Cell Lines: A New Potential Virotherapy Approach.

Journal: Viruses

Published: September 22, 2021

RBL1/p107 Expression Levels Are Modulated by Multiple Signaling Pathways.

RBL1/p107 Expression Levels Are Modulated by Multiple Signaling Pathways.

Journal: Cancers

Published: July 20, 2021

Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma.

Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma.

Journal: Cell death & disease

Published: October 17, 2020

Pharmacological Inhibition of WEE1 Potentiates the Antitumoral Effect of the dl922-947 Oncolytic Virus in Malignant Mesothelioma Cell Lines.

Pharmacological Inhibition of WEE1 Potentiates the Antitumoral Effect of the dl922-947 Oncolytic Virus in Malignant Mesothelioma Cell Lines.

Journal: International journal of molecular sciences

Published: August 04, 2020

Showing 1-12 of 23

Last Updated: 09/26/2026